A comparative analysis of infection in patients with malignant cancer: A clinical pharmacist consultation study
Journal of Infection and Public Health2019Vol. 12(6), pp. 789–793
Citations Over TimeTop 25% of 2019 papers
Lin Li, Lihua Jia, Yali Fu, Ruonan Zhao, Yuan Huang, Chuanhao Tang, Chao Meng, Dazhong Zhao, Jun Liang
Abstract
Patients with malignant cancer are more likely to suffer from an infection containing pathogenic bacteria in comparison to benign patients. There have been considerable differences in the composition of pathogenic bacteria and its resistance to drugs. Overall, evaluating pathogens plays an essential role in the anti-infection treatment of patients with malignant cancer.
Related Papers
- → The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit(2017)58 cited
- → Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies(2021)17 cited
- Research and practice on hospital clinical pharmacist system construction(2011)
- → Retrospective Assessment of the Clinical Pharmacist Sheets among a Few Iraqi General Hospitals(2021)2 cited
- Review and thoughts of establishing clinical pharmacist institutional(2007)